NAMFERO
Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Oct 2025)
What this means for you
This application is over — abandoned 10 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90518812
- Mark type
- Stylized text
- Filed
- 08 Feb 2021
- Published for opposition
- 18 Jan 2022
- Abandoned
- 10 Oct 2025
- Attorney of record
- Fara S. Sunderji
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
Owner
- Purdue Pharma L.P., Stamford, CT, US
- Purdue Pharma L.P., Stamford, CT, US
Prosecution history
- 10 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 10 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 16 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Sept 2024 — SOU EXTENSION 5 GRANTED
- 16 Sept 2024 — SOU EXTENSION 5 FILED
- 16 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2024 — SOU EXTENSION 4 GRANTED
- 12 Mar 2024 — SOU EXTENSION 4 FILED
- 12 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 12 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Sept 2023 — SOU EXTENSION 3 GRANTED
- 08 Sept 2023 — SOU EXTENSION 3 FILED
- 08 Sept 2023 — SOU TEAS EXTENSION RECEIVED
- 07 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED